𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study

✍ Scribed by Adel Gabriel

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
101 KB
Volume
23
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Olanzapine augmentation of milnacipran f
Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study
✍ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatment‐resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz

Thyroxine Augmentation of Fluoxetine Tre
Thyroxine Augmentation of Fluoxetine Treatment for Resistant Depression in the Elderly: An Open Trial
✍ YORAM BARAK; DANIEL STEIN; JOSEPH LEVINE; ALIZA RING; JACK HADJEZ; AVNER ELIZUR; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro

Paroxetine in the treatment of depressed
Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study
✍ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a

Celecoxib as an adjunct in the treatment
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
✍ Fabiano G. Nery; Emel S. Monkul; John P. Hatch; Manoela Fonseca; Giovana B. Zunt πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## Objective To investigate whether the cox‐2 inhibitor celecoxib has antidepressant effects in bipolar disorder (BD) patients during depressive or mixed phases. ## Methods We studied 28 DSM‐IV BD patients who were experiencing a depressive or mixed episode and were on a stable dose